Savara (SVRA) Times Interest Earned (2011 - 2026)
Savara's (SVRA) quarterly Times Interest Earned came in at -$63.19 in Q1 2026, down 194.46% year-on-year from $66.9 in Q1 2025, and down 547.96% on a QoQ basis from $14.11 in Q4 2025.
Savara (SVRA) Times Interest Earned (2011 - 2026) Analysis & Trends
Savara (SVRA) has 16 years of Times Interest Earned data on file, last reported at -$63.19 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 194.46% year-over-year to -$63.19 in Q1 2026; TTM through Mar 2026 was -$1719.3, a 4470.85% decrease from a year earlier, with the FY2025 full-year figure at -$0.87, up 9.95% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$63.19, down from $14.11 in the prior quarter.
- Over the last five years, Times Interest Earned for SVRA reached as high as $14.11 in Q4 2025 and fell as low as -$982.5 in Q2 2025.
- Historically, Times Interest Earned has averaged -$96.23 across 5 years, with a median of -$30.93 in 2023.
- On a YoY basis, Times Interest Earned climbed as much as 122.85% in 2025 and fell as far as 1209.15% in 2025.
- Year by year, Times Interest Earned stood at -$25.41 in 2022, then declined by 29.45% to -$32.89 in 2023, then plunged by 87.68% to -$61.73 in 2024, then jumped by 122.85% to $14.11 in 2025, then plunged by 547.96% to -$63.19 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$63.19 in Q1 2026, $14.11 in Q4 2025, and -$982.5 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | -63.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.19 |
| Dec 31, 2025 | 14.11 |
| Jun 30, 2025 | -982.50 |
| Mar 31, 2025 | -21.46 |
| Dec 31, 2024 | -61.73 |
| Sep 30, 2024 | -93.80 |
| Jun 30, 2024 | -75.05 |
| Mar 31, 2024 | -41.93 |
| Dec 31, 2023 | -32.89 |
| Sep 30, 2023 | -45.80 |
| Jun 30, 2023 | -28.96 |
| Mar 31, 2023 | -26.10 |
| Dec 31, 2022 | -25.41 |
| Sep 30, 2022 | -20.82 |
| Jun 30, 2022 | -17.54 |
| Mar 31, 2022 | -16.62 |
| Dec 31, 2021 | -21.28 |
| Sep 30, 2021 | -100.73 |
| Jun 30, 2021 | -92.50 |
| Mar 31, 2021 | -21.52 |